There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ResMed stock.
Is ResMed a buy or sell?
ResMed has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 5 buy ratings, 4 hold ratings, and 1 sell rating.
Does ResMed pay a dividend?
ResMed (NYSE:RMD) pays quarterly dividends to shareholders.
Does ResMed have a dividend reinvestment plan?
ResMed does not offer a dividend reinvestment program.
Is RMD stock a buy?
10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ResMed in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ResMed stock.
How much will a dividend pay?
How do stock dividends work? A dividend is paid per share of stock — if you own 30 shares in a company and that company pays $2 in annual cash dividends, you will receive $60 per year.
Is ResMed overvalued?
The stock of ResMed (NYSE:RMD, 30-year Financials) is believed to be modestly overvalued, according to GuruFocus Value calculation. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance.Jun 6, 2021